(S (NP (JJ Clinical) (NN decision) (NN support) (NNS systems)) (VP (VBP have) (VP (VBN been) (VP (VBN developed) (S (VP (TO to) (VP (VB help) (S (NP (NNS physicians)) (VP (TO to) (VP (VB take) (NP (JJ clinical) (NNS guidelines)) (PP (IN into) (NP (NN account))) (PP (IN during) (NP (NNS consultations)))))))))))) (. .))
(S (S (NP (DT The) (NNP ASTI) (NN critiquing) (NN module)) (VP (VBZ is) (NP (CD one) (JJ such) (NNS systems)))) (: ;) (S (NP (PRP it)) (VP (VBZ provides) (NP (DT the) (NN physician)) (PP (IN with) (NP (JJ automatic) (NNS criticisms))) (SBAR (WHADVP (WRB when)) (S (NP (DT a) (NN drug) (NN prescription)) (VP (VBZ does) (RB not) (VP (VB follow) (NP (DT the) (NNS guidelines)))))))) (. .))
(S (NP (PRP It)) (VP (VP (VBD was) (ADVP (RB initially)) (VP (VBN developed) (PP (IN for) (NP (NP (NN hypertension)) (CC and) (NP (NN type) (CD 2) (NNS diabetes)))))) (, ,) (CC but) (VP (VBZ is) (VP (VBN designed) (S (VP (TO to) (VP (VB be) (ADJP (JJ generic) (RB enough) (PP (IN for) (NP (NP (NN application)) (PP (TO to) (NP (DT all) (JJ chronic) (NNS diseases)))))))))))) (. .))
(S (S (NP (PRP We)) (VP (VBP present) (ADVP (RB here)) (NP (NP (DT the) (NNS results)) (PP (IN of) (NP (NP (NN usability) (CC and) (NN satisfaction) (NNS evaluations)) (PP (IN for) (NP (DT the) (NNP ASTI) (NN critiquing) (NN module))) (, ,) (VP (VBN obtained) (PP (IN with) (NP (NNP GPs))) (PP (IN for) (NP (NP (DT a) (ADJP (RB newly) (VBN implemented)) (NN guideline)) (VP (VBG concerning) (NP (NN dyslipaemia))))))))))) (, ,) (CC and) (S (NP (PRP we)) (VP (VBP discuss) (NP (NP (NP (DT the) (NNS lessons)) (VP (NN learnt))) (CC and) (NP (NP (DT the) (NNS difficulties)) (VP (VBD encountered) (SBAR (WHADVP (WRB when)) (S (VP (VBG building) (NP (NP (DT a) (JJ generic) (NNP DSS)) (PP (IN for) (S (VP (VBG critiquing) (NP (NP (NNS physicians) (POS â€º)) (NNS prescriptions)))))))))))))) (. .))
